INM peer analysis
InMed Pharmaceuticals (INM) against its competitors: price, today's move, 1-year return and market value side by side.
- INM's peers: BDRX (Biodexa Pharmaceuticals), BIVI (BioVie), CNSP (CNS Pharmaceuticals), ESLA (Estrella Immunopharma), GNPX (Genprex), GRI (GRI Bio), JAGX (Jaguar Health), KZIA (Kazia Therapeutics).
INM and its peers
| Company | Price | Today | 1-year return | Market cap |
|---|---|---|---|---|
| BDRX Biodexa Pharmaceuticals | $1.95 | -2.26% | -98.74% | $181.86K |
| BIVI BioVie | $0.80 | -12.07% | -41.61% | $8.58M |
| CNSP CNS Pharmaceuticals | $3.92 | -11.82% | -41.57% | $5.78M |
| ESLA Estrella Immunopharma | $0.32 | -5.73% | -81.66% | $14.11M |
| GNPX Genprex | $1.67 | -2.34% | -97.73% | $843.24K |
| GRI GRI Bio | $1.12 | -11.81% | -97.63% | $2.45M |
| JAGX Jaguar Health | $0.22 | -32.42% | -99.97% | $2.95M |
| KZIA Kazia Therapeutics | $5.05 | -5.96% | -34.75% | $8.18M |
| SILO Silo Pharma | $1.88 | -0.53% | -68.27% | $4.05M |
| INM InMed Pharmaceuticals | $15.56 | 17.79% | 812.61% | – |